These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury. Cross HR; Steenbergen C; Lefkowitz RJ; Koch WJ; Murphy E Circ Res; 1999 Nov; 85(11):1077-84. PubMed ID: 10571539 [TBL] [Abstract][Full Text] [Related]
9. Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. Iaccarino G; Rockman HA; Shotwell KF; Tomhave ED; Koch WJ Am J Physiol; 1998 Oct; 275(4):H1298-306. PubMed ID: 9746479 [TBL] [Abstract][Full Text] [Related]
10. Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex. Perrino C; Naga Prasad SV; Schroder JN; Hata JA; Milano C; Rockman HA Circulation; 2005 May; 111(20):2579-87. PubMed ID: 15897344 [TBL] [Abstract][Full Text] [Related]
11. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Rockman HA; Chien KR; Choi DJ; Iaccarino G; Hunter JJ; Ross J; Lefkowitz RJ; Koch WJ Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7000-5. PubMed ID: 9618528 [TBL] [Abstract][Full Text] [Related]
12. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Anderson KM; Eckhart AD; Willette RN; Koch WJ Hypertension; 1999 Jan; 33(1 Pt 2):402-7. PubMed ID: 9931137 [TBL] [Abstract][Full Text] [Related]
13. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor. Tevaearai HT; Eckhart AD; Shotwell KF; Wilson K; Koch WJ Circulation; 2001 Oct; 104(17):2069-74. PubMed ID: 11673348 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy. Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854 [TBL] [Abstract][Full Text] [Related]
16. Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. Harding VB; Jones LR; Lefkowitz RJ; Koch WJ; Rockman HA Proc Natl Acad Sci U S A; 2001 May; 98(10):5809-14. PubMed ID: 11331748 [TBL] [Abstract][Full Text] [Related]
17. Expression of a beta-adrenergic receptor kinase inhibitor reverses dysfunction in failing cardiomyocytes. Eckhart AD; Koch WJ Mol Ther; 2002 Jan; 5(1):74-9. PubMed ID: 11786048 [TBL] [Abstract][Full Text] [Related]
18. Enhanced contractility and decreased beta-adrenergic receptor kinase-1 in mice lacking endogenous norepinephrine and epinephrine. Cho MC; Rao M; Koch WJ; Thomas SA; Palmiter RD; Rockman HA Circulation; 1999 May; 99(20):2702-7. PubMed ID: 10338466 [TBL] [Abstract][Full Text] [Related]
19. betaARK1 inhibition improves survival in a mouse model of heart failure induced by myocardial infarction. Suzuki Y; Nakano K; Sugiyama M; Imagawa J J Cardiovasc Pharmacol; 2004 Sep; 44(3):329-34. PubMed ID: 15475830 [TBL] [Abstract][Full Text] [Related]
20. Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated beta-adrenergic signaling modulation. Tevaearai HT; Walton GB; Eckhart AD; Keys JR; Koch WJ Eur J Cardiothorac Surg; 2002 Nov; 22(5):733-7. PubMed ID: 12414039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]